Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

New compounds may help treat heart disease by activating specific potassium channels.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Clascoterone may be an effective topical treatment for hair loss.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Clascoterone may be a promising treatment for hair loss.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The new compound may be a safer alternative to finasteride for prostate protection.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Fractional radiofrequency effectively and safely improves rosacea symptoms.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib effectively treats alopecia areata with manageable side effects.